FIBROGEN INC — Director's Dealing 2025

Mar 25, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2025-03-24

Reporting Person: Wettig Thane (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-24	Common Stock	P	145000	$0.3494	Acquired	543329	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1000	Indirect

Footnotes

F1: Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $0.34 to $0.37. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.